Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
Limited chemical diversity of nucleic acid libraries has long been suspected to be a major constraining factor in the overall success of SELEX (Systematic Evolution of Ligands by EXponential enrichment). Despite this constraint, SELEX has enjoyed considerable success over the past quarter of a centu...
Saved in:
Main Authors: | John C Rohloff (Author), Amy D Gelinas (Author), Thale C Jarvis (Author), Urs A Ochsner (Author), Daniel J Schneider (Author), Larry Gold (Author), Nebojsa Janjic (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents
by: Amy D. Gelinas, et al.
Published: (2023) -
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
by: Lin Zhang, et al.
Published: (2022) -
Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
by: Silvia Catuogno, et al.
Published: (2018) -
Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging
by: Leila Hassanzadeh, et al.
Published: (2018) -
Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands
by: Hasan E. Zumrut, et al.
Published: (2019)